Cramer’s lightning round: Stay long on CF Industries

Cramer’s lightning round: Stay long on CF Industries


ON Semiconductor Corp: “Right now, I’ve got a pause on the semis. Why? Because we’ve got so many problems right now in China.”

Dutch Bros Inc: “I want you to put half the position on now, and then half when it goes below $30. … I like the stock, though.”

NIO Inc: “I have to say no to that. … I think that that stock is not a buy.”

Cinemark Holdings Inc: “This is a very difficult business. … I’m going to have to say, once again, [don’t buy.]”

Cano Health Inc: “I like the healthcare space, I think they do quality healthcare work, and I’m going to have to say that I think it’s worth buying.”

Uranium Energy Corp: “There’s been no real sign that we’re going back to nuclear. … I have to say, [don’t buy].”

Cramer's lightning round: Stay long on CF Industries

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

‘Marriage penalty’ in Washington state’s new millionaire tax stirs debate
Business

‘Marriage penalty’ in Washington state’s new millionaire tax stirs debate

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Washington state’s proposed new income tax includes the largest “marriage penalty” in the nation, placing higher taxes on certain couples who file jointly, […]

Read More
FedEx beats on top and bottom lines, raises guidance on strong performance
Business

FedEx beats on top and bottom lines, raises guidance on strong performance

Rear view of FedEx delivery truck with logo parked on city street, Dogpatch Neighborhood, San Francisco, California, February 25, 2026. Smith Collection/gado | Archive Photos | Getty Images FedEx on Thursday reported strong fiscal third-quarter results that beat Wall Street’s expectations. The company also raised its guidance for fiscal 2026, projecting revenue growth of 6% […]

Read More
FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share
Business

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026. Tom Little | Reuters The Food and Drug Administration on Thursday approved a higher dose version of Novo Nordisk‘s blockbuster weight loss injection Wegovy, as the company pushes to win back market share from […]

Read More